Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.

ClinicalTrials.gov ID: NCT05288504

Public ClinicalTrials.gov record NCT05288504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of AVTX-002 compared with placebo in patients with poorly controlled non-eosinophilic asthma (NEA).

Study identification

NCT ID
NCT05288504
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Avalo Therapeutics, Inc.
Industry
Enrollment
91 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 24, 2022 (Actual)
Primary completion
May 11, 2023 (Actual)
Completion
May 11, 2023 (Actual)
Last update posted
Sep 5, 2024

2022 – 2023

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Tucson Neuroscience Research - M3, Wake Research Tucson Arizona 85710 —
Center For Clinical Trials of Sacramento Sacramento California 95823 —
Allergy and Asthma Medical Group of the Bay Area Walnut Creek California 94598 —
Center For Clinical Trials of San Gabriel West Covina California 91790-3402 —
IMMUNOe Research Centers Centennial Colorado 80112 —
National Jewish Health Denver Colorado 80206 —
Helix Biomedics, LLC Boynton Beach Florida 33435 —
Suncoast Research Group LLC Miami Florida 33135 —
Suncoast Research Associates LLC Miami Florida 33137 —
Pro-Care Research Center, Corp. Miami Gardens Florida 33014 —
Innovation Medical Research Center Palmetto Bay Florida 33157 —
ASHA Clinical Research-Munster, LLC Hammond Indiana 46324 —
Family Allergy and Asthma Research Institute Louisville Kentucky 40215 —
Continental Clinical Solutions, LLC Towson Maryland 21212 —
Pulmonary Research Institute of Southeast Michigan Farmington Hills Michigan 48336 —
Midwest Clinical Research St Louis Missouri 63141 —
Meridian Clinical Research Lincoln Nebraska 68510 —
OK Clinical Research Edmond Oklahoma 73034 —
Affinity Health Nashville Tennessee 37203 —
Amarillo Center For Clinical Research Amarillo Texas 79124 —
South Texas Medical Research Institute, Inc Boerne Texas 78006 —
Pioneer Research Solutions Houston Texas 77099 —
Meridian Clinical Research Portsmouth Virginia 23703 —
Clinical Research Partners, LLC Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05288504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 5, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05288504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →